International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Scopus by Title (Ref)
1. Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves’ orbitopathy
- Jian H. , et al.
2. No retinopathy after orbital irradiation in patients with thyroid eye disease – a follow up study
- Makhoul S. , et al.
3. Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review
- Verrienti M. , et al.
4. Management of Graves’ ophthalmopathy by radiotherapy: A literature review
- Beige A. , et al.
5. Stereotactic radiotherapy of radiation-induced meningioma previously irradiated retrobulbar for Graves' ophthalmopathy: A case report
- Tachizawa N. , et al.
6. Novel Immunomodulatory Treatment Modalities for Thyroid-Associated Orbitopathy
- Strianese D. , et al.
7. Changes in therapeutic response, ocular manifestations of Graves’ orbitopathy and quality of life during the first year after orbital radiotherapy
- Stoynova M.A. , et al.
8. Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy
- Lu T.J. , et al.
9. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology
- Sobel R.K. , et al.
10. Graves’ orbitopathy: diagnosis, epidemiology and treatments
- Lun A.Y. , et al.
11. Discussion on treatment of thyroid associated ophthalmopathy based on "state-target theory" with Traditional Chinese Medicine
- Han X. , et al.
12. Orbital radiotherapy for proptosis in patients with Graves’ ophthalmopathy
- Ding B.Y. , et al.
13. Thyroid eye disease: Redefining its management—A review
- Jain A.P. , et al.
14. Current Role and Historical Roots of Radiotherapy in Thyroid Eye Disease
- Siktberg J. , et al.
15. The role of autophagy in thyroid-related ophthalmopathy
- Yuan S.S. , et al.
16. Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
- Limone P.P. , et al.
17. Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy
- Slentz D.H. , et al.
18. Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review
- Hodgson N.M. , et al.
19. Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy
- Smith T.J. , et al.